Page 40 - Gates-AnnualReport-2015

Left to Right: Associate Vice Chancellor for Advancement Jim Hodge and Department of Ophthalmology Chair and Sue Anschutz-Rodgers Endowed Chair in Retinal Diseases, Naresh Mandava, MD, tour the Gates Biomanufacturing Facility. The recently funded Ocular Stem Cell and Regeneration Program aspires to produce therapeutic stem cells in the facility so as to surgically deliver them into the eyes of patients to treat age-related macular degeneration.
GATES CENTER OPERATIONS
In 2015, the Gates Center finalized a five-year funding agreement between the University of Colorado Foundation, the University of Colorado President’s Office and the Gates Frontiers Fund to support the Gates Center for Regenerative Medicine’s basic research, general operations, education and outreach programs, and technology upgrades through the year 2020.
Consistent with its mission of providing research funding, core equipment and services to its members, along with fundraising assistance and commercialization support, the center’s top expense categories in 2015 were Program and Research Support $752,000 (34%), Core Operations and Core/Center Equipment $618,000 (28%), Marketing and Development $339,000 (16%) and Center Administration $336,000 (15%). The balance of expenses totaling 7% includes Education, Enrichment, Strategic Planning Consulting and Patent Expense.
As of December 30, 2015, the center’s combined fund balance was $28,525.
GOING FORWARD
• We will continue to strategically leverage private contributions and pre-clinical investments to accelerate Gates Center member research and help us remain competitive for increasingly scarce federal funding.
• We have an excellent track record of matching benefactor intent with research opportunities, and we will continue to market our most promising research to a broader philanthropic community.
• The Gates Center will leverage operational support from the CU Foundation, the University of Colorado President’s Office and the Gates Frontiers Fund to stimulate recurring and diversified revenues and other sources of funding to support our operations beyond the year 2020.
• The Gates Center will strive to remain ahead of the technology curve in our core facilities, which are among the key resources we provide for our members.
40
Gates Center for Regenerative Medicine